Uniform protein labeling in intact tissues is a challenge. An approach that allows antibodies to seep within organs could ...

Chugai Pharm signs collaboration agreement with GSK's Global Health Unit for development of anti-dengue virus antibody: Tokyo Friday, January 31, 2025, 09:00 Hrs [IST] Chugai Phar ...

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company focused on developing innovative therapies for ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

From saying goodbye to privacy and personal space to welcoming in more joy and laughter, pets change our lives in the most ...

Leap Therapeutics (NASDAQ:LPTX – Get Free Report) was downgraded by Baird R W from a “strong-buy” rating to a “hold” rating in a research note issued on Wednesday,Zacks.com reports. Several other ...

Welcome to the AbbVie fourth-quarter 2024 Earnings Conference Call. [Operator instructions] Today's call is also being ...

PureTech Health plc (NASDAQ:PRTC – Get Free Report) saw a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 24,600 shares, a decline ...

Aethlon announces first patient enrolled and treated with the Hemopurifier at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital: San Diego Friday, January 31, 2025, 1 ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.